Ledger.Open graph →
SEC Form D · filed October 15, 2019

Cyteir Therapeutics, Inc

Offering
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Markus Renschler · LEXINGTON, MAExec · DirectorRacquel Bracken · LEXINGTON, MADirectorTimothy S. Romberger · LEXINGTON, MAExec · DirectorJean George · LEXINGTON, MADirectorJanwillem Naesens · LEXINGTON, MADirectorKaren Hong · LEXINGTON, MADirectorEnrico Scolari · San Diego, CAExec · DirectorFraser R. Edison · St. John's, Newfoundland and Labrador, CanadaDirectorFrank G. Haluska · Wayland, MADirectorBrian Hardecker · Long Island City, NYExec · DirectorJohn R. Anderson · St. John's, Newfoundland and Labrador, CanadaDirectorCarson R. Noel · St. John's, Newfoundland and Labrador, CanadaDirectorCarl Schoellhammer · Cambridge, MADirectorRobert Langer · Cambridge, MADirectorAndrew Klaber · New York, NYDirectorInvestment Advisor Pgim Limited · Newark, NJExec · DirectorMatthew Schutzman · Munster, INDirectorZak Nugent · Cottonwood Heights, X1Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗